Per Alex Berenson on Twitter Files
Pfizer's Scott Gottlieb Emailed Top Lobbyist in Twitter's Washington Office Over Covid Vaccine Comments
1/10/2023
A recent Twitter Files series revealed how a board member of Pfizer secretly sent an email to a top lobbyist in Twitter's Washington office over a statement from an esteemed Dr. Brett Giroir regarding Covid vaccines.
As per the report, Pfizer board member Scott Gottlieb spotted a tweet explaining the difference between vaccine protection and natural immunity built after contracting Covid. Per the tweet, the latter was more effective.
The tweet came from Dr. Brett Giroir, a Food & Drug Administration head who shortly followed Gottlieb in his position. Dr. Giroir, a physician, gave a statement comparing natural immunity to immunity cultivated after getting the Covid vaccine.
Dr. Brett Giroir: "It's now clear #COVID19 natural immunity is superior to #vaccine immunity, by ALOT. There would be no science justification for #vax proof if a person had prior infection. @CDCDirector @POTUS must follow the science. If no previous infection? Get vaccinated!"
Pfizer competitor Moderna recently suggested that it is considering a $110-$130 price for Covid vaccines despite its initial costs at just $15 to $16 per dose.
Despite still encouraging people to get vaccinated if they don't have a history of Covid infection, Dr. Gottlieb, a Pfizer senior board member, former FDA commissioner, and a CNBC contributor, decided to email a top lobbyist in Twitter's Washington office, Todd O'Boyle, to share concerns of the post being corrosive and that it could become viral.
As uploaded by Alex Berenson in his substack, a screenshot of an email showed Gottlieb's message to O'Boyle regarding the tweet.
Gottlieb: "This is the kind of stuff that's corrosive. Here he draws a sweeping conclusion from a single retrospective study in Israel that hasn't been peer-reviewed. But this tweet will end up going viral and driving news coverage.
Despite the world slowly easing up on Covid restrictions, nearing the end of 2022, two flights from China to Milan actually showed that almost half of the passengers tested positive for Covid-19.
In 2021, Pfizer's mRNA jabs resulted in half its $81 billion in sales. That year, Gottlieb was paid roughly $365,000, roughly $1,000 per day.
See flow at unusualwhales.com/flow.
Other News:
- Moderna, MRNA, considers price of $110-$130 for covid-19 vaccine
- Two Flights to Milan from China Showed Almost Half of the Passengers were Positive for COVID-19
Resources:
Elon Musk has said: The Trump tariffs will cause a recession in the second half of this year
6/5/2025 8:32 PMTrump has said: I don’t mind Elon turning against me, but he should have done so months ago
6/5/2025 8:27 PMElon Musk has endorsed a post saying Trump should be impeached
6/5/2025 8:26 PMElon Musk has said: In light of the President’s statement about cancellation of my government contracts, SpaceX will begin decommissioning its Dragon spacecraft immediately
6/5/2025 8:22 PM
Stay Updated
Subscribe to our newsletter for the latest financial insights and news.
Unusual Whales does not confirm the information's truthfulness or accuracy of the associated references, data, and cannot verify any of the information. Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Options, investing, trading is risky, and losses are more expected than profits. Please do own research before investing. Please only subscribe after reading our full terms and understanding options and the market, and the inherent risks of trading. It is highly recommended not to trade on this, or any, information from Unusual Whales. Markets are risky, and you will likely lose some or all of your capital. Please check our terms for full details.
Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. See terms for more information.